Pediatric Gastroenterology & Nutrition, Geisinger, Danville, PA, USA.
Biomedical and Translational Informatics, Geisinger, Danville, PA, USA.
Dis Esophagus. 2022 Oct 14;35(10). doi: 10.1093/dote/doac012.
Eosinophilic Esophagitis (EoE) is an esophageal allergic inflammatory disorder triggered by food proteins. Symptoms of EoE are variable within and between individuals. Presenting symptoms may include dysphagia, food bolus impaction, dyspepsia, or more subtle symptoms such as feeding disorders, regurgitation sensation, or nausea. The development and validation of a pediatric EoE patient self-reported and parent proxy-reported outcome symptom scoring tool was created by Franciosi et al. published in BMJ 2011, titled the Pediatric Eosinophilic Esophagitis Symptom Score (PEESS™ v2.0). To date, its use is largely for research purposes. We propose to evaluate the implementation of the PEESS™ v2.0 in a prospective interventional controlled clinical practice. The study included 620 patients over an 18-month period. Surveys were delivered and administered digitally every month through the MyGeisinger.org Patient Portal. Our analysis demonstrated symptom severity and symptom frequency scores significantly improved over time. However, counter to our hypothesis, patients who completed the PEESS™v2.0 ultimately had higher EoE-related health care utilization of office visits and endoscopies compared with those who did not complete the PEESS™v2.0. This could be related to greater awareness of disease activity and/or increased willingness to seek care. Our study, in the context of mobile health tool and patient-reported outcome trends, represents an opportunity for improved disease monitoring at-home within the field of eosinophilic gastrointestinal diseases.
嗜酸粒细胞性食管炎 (EoE) 是一种由食物蛋白引发的食管过敏性炎症性疾病。EoE 的症状在个体之间和个体内部存在差异。其表现症状可能包括吞咽困难、食物团块嵌塞、消化不良,或更微妙的症状,如喂养障碍、反流感或恶心。由 Franciosi 等人发表在 2011 年的《英国医学杂志》上的研究创建了一种儿科嗜酸粒细胞性食管炎患者自我报告和家长代理报告的结局症状评分工具,即儿科嗜酸粒细胞性食管炎症状评分 (PEESS™ v2.0)。迄今为止,它的应用主要是为了研究目的。我们拟在一项前瞻性干预性对照临床实践中评估 PEESS™ v2.0 的实施情况。该研究在 18 个月的时间内纳入了 620 名患者。通过 MyGeisinger.org 患者门户每月以数字化方式进行调查和管理。我们的分析表明,症状严重程度和症状频率评分随时间显著改善。然而,与我们的假设相反,完成了 PEESS™ v2.0 的患者最终比未完成 PEESS™ v2.0 的患者有更高的与 EoE 相关的医疗保健利用率,包括就诊次数和内镜检查。这可能与对疾病活动的认识增加和/或更愿意寻求医疗护理有关。在移动医疗工具和患者报告结果趋势的背景下,我们的研究代表了在家中改善嗜酸细胞性胃肠道疾病监测的机会。